Alterity Therapeutics vision for neurodegenerative care - Proactive Investors USA

ATHE Stock  USD 3.34  0.06  1.83%   
About 54% of Alterity Therapeutics' shareholders are presently thinking to get in. The analysis of the overall investor sentiment regarding Alterity Therapeutics suggests that some traders are interested. The current market sentiment, together with Alterity Therapeutics' historical and current headlines, can help investors time the market. In addition, many technical investors use Alterity Therapeutics stock news signals to limit their universe of possible portfolio assets.
  
Alterity Therapeutics vision for neurodegenerative care Proactive Investors USA

Read at news.google.com
Google News at Macroaxis
  

Alterity Therapeutics Fundamental Analysis

We analyze Alterity Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Alterity Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Alterity Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Total Debt

Total Debt Comparative Analysis

Alterity Therapeutics is currently under evaluation in total debt category among its peers. Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.

Alterity Therapeutics Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Alterity Therapeutics stock to make a market-neutral strategy. Peer analysis of Alterity Therapeutics could also be used in its relative valuation, which is a method of valuing Alterity Therapeutics by comparing valuation metrics with similar companies.

Peers

Alterity Therapeutics Related Equities

RNAZTranscode Therapeutics   57.59   
0%
100.0%
ATXIAvenue Therapeutics   6.36   
0%
11.0%
MNPRMonopar Therapeutics   6.28   
0%
10.0%
PMVPPmv Pharmaceuticals   5.30   
0%
9.0%
ADILAdial Pharmaceuticals   2.08   
0%
3.0%
ARTLArtelo Biosciences   1.69   
0%
2.0%
ANTXAN2 Therapeutics   0.79   
1.0%
0%
TARAProtara Therapeutics   1.47   
2.0%
0%
SRZNSurrozen   1.54   
2.0%
0%
ANEBAnebulo Pharmaceuticals   1.86   
3.0%
0%
RVPHReviva Pharmaceuticals   2.58   
4.0%
0%
HCWBHCW Biologics   2.86   
4.0%
0%
ADTXAditxt   8.33   
14.0%
0%
NBYNovaBay Pharmaceuticals   12.35   
21.0%
0%
QNRXQuoin Pharmaceuticals   30.51   
52.0%
0%

Complementary Tools for Alterity Stock analysis

When running Alterity Therapeutics' price analysis, check to measure Alterity Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alterity Therapeutics is operating at the current time. Most of Alterity Therapeutics' value examination focuses on studying past and present price action to predict the probability of Alterity Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alterity Therapeutics' price. Additionally, you may evaluate how the addition of Alterity Therapeutics to your portfolios can decrease your overall portfolio volatility.
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
CEOs Directory
Screen CEOs from public companies around the world
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites